{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T15:13:25Z","timestamp":1788362005662,"version":"build-2803163510"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,13]]},"DOI":"10.7759\/cureus.64468","type":"journal-article","created":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T15:06:02Z","timestamp":1720883162000},"source":"Crossref","is-referenced-by-count":1,"title":["Unveiling the Preparation and Characterization of Lercanidipine Hydrochloride in an Oral Solid Self-Nanoemulsion for Enhancing Oral Delivery"],"prefix":"10.7759","author":[{"given":"Haneen M","family":"Abdul Hussein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mowafaq M","family":"Ghareeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.22270\/jddt.v13i8.5942","article-title":"Formulation development and characterization of lecarnidipine hydrochloride niosomal transdermal patches","volume":"13","author":"Padmaja B","year":"2023","unstructured":"Padmaja B, Rani SS. Formulation development and characterization of lecarnidipine hydrochloride niosomal transdermal patches. J Drug Deliv Ther. 2023, 13:100-9. 10.22270\/jddt.v13i8.5942","journal-title":"J Drug Deliv Ther"},{"key":"ref2","article-title":"Antihypertensive treatment with calcium channel blockers and renal protection: focus on lercanidipine and lercanidipine\/enalapril","volume":"26","author":"Ferri N","year":"2022","unstructured":"Ferri N, Corsini A, Pontremoli R. Antihypertensive treatment with calcium channel blockers and renal protection: focus on lercanidipine and lercanidipine\/enalapril. Eur Rev Med Pharmacol Sci. 2022, 26:7482-92.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref3","article-title":"Lercanidipine in hypertension","volume":"1","author":"Borghi C","year":"2005","unstructured":"Borghi C. Lercanidipine in hypertension. Vasc Health Risk Manag. 2005, 1:173-82.","journal-title":"Vasc Health Risk Manag"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241814048","article-title":"New insights into the nephroprotective potential of lercanidipine","volume":"24","author":"Hajdys J","year":"2023","unstructured":"Hajdys J, Fularski P, Leszto K, et al.. New insights into the nephroprotective potential of lercanidipine. Int J Mol Sci. 2023, 24:14048. 10.3390\/ijms241814048","journal-title":"Int J Mol Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2019.08.030","article-title":"Chronic kidney disease: biomarker diagnosis to therapeutic targets","volume":"499","author":"Wang YN","year":"2019","unstructured":"Wang YN, Ma SX, Chen YY, Chen L, Liu BL, Liu QQ, Zhao YY. Chronic kidney disease: biomarker diagnosis to therapeutic targets. Clin Chim Acta. 2019, 499:54-63. 10.1016\/j.cca.2019.08.030","journal-title":"Clin Chim Acta"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-010-0141-3","article-title":"Chronic kidney disease and albuminuria in arterial hypertension","volume":"12","author":"Leoncini G","year":"2010","unstructured":"Leoncini G, Viazzi F, Pontremoli R. Chronic kidney disease and albuminuria in arterial hypertension. Curr Hypertens Rep. 2010, 12:335-41. 10.1007\/s11906-010-0141-3","journal-title":"Curr Hypertens Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4103\/jpp.JPP_34_17","article-title":"Lercanidipine in the management of hypertension: an update","volume":"8","author":"Grassi G","year":"2017","unstructured":"Grassi G, Robles NR, Seravalle G, Fici F. Lercanidipine in the management of hypertension: an update. J Pharmacol Pharmacother. 2017, 8:155-65. 10.4103\/jpp.JPP_34_17","journal-title":"J Pharmacol Pharmacother"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics8030020","article-title":"Novel solid self-nanoemulsifying drug delivery system (S-SNEDDS) for oral delivery of olmesartan medoxomil: design, formulation, pharmacokinetic and bioavailability evaluation","volume":"8","author":"Nasr A","year":"2016","unstructured":"Nasr A, Gardouh A, Ghorab M. Novel solid self-nanoemulsifying drug delivery system (S-SNEDDS) for oral delivery of olmesartan medoxomil: design, formulation, pharmacokinetic and bioavailability evaluation. Pharmaceutics. 2016, 8:20. 10.3390\/pharmaceutics8030020","journal-title":"Pharmaceutics"},{"key":"ref9","article-title":"Preparation and evaluation of liquid and solid self-microemulsifying drug delivery system of mebendazole","volume":"23","author":"Hussein AA","year":"2014","unstructured":"Hussein AA. Preparation and evaluation of liquid and solid self-microemulsifying drug delivery system of mebendazole. Iraqi J Pharm Sci. 2014, 23:89-100.","journal-title":"Iraqi J Pharm Sci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/848043","article-title":"Formulation strategies to improve the bioavailability of poorly absorbed drugs with special emphasis on self-emulsifying systems","volume":"2013","author":"Gupta S","year":"2013","unstructured":"Gupta S, Kesarla R, Omri A. Formulation strategies to improve the bioavailability of poorly absorbed drugs with special emphasis on self-emulsifying systems. ISRN Pharm. 2013, 2013:848043. 10.1155\/2013\/848043","journal-title":"ISRN Pharm"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.47750\/pnr.2022.13.03.044","article-title":"Preparation and in-vivo evaluation of ticagrelor oral liquid self nano-emulsion","volume":"13","author":"Khalid KW","year":"2022","unstructured":"Khalid KW, Abd Alhammid SN. Preparation and in-vivo evaluation of ticagrelor oral liquid self nano-emulsion. J Pharm Negat Results. 2022, 13:274. 10.47750\/pnr.2022.13.03.044","journal-title":"J Pharm Negat Results"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1080\/10717544.2023.2288801","article-title":"Quality by design aided self-nano emulsifying drug delivery systems development for the oral delivery of benidipine: improvement of biopharmaceutical performance","volume":"31","author":"Buddhadev SS","year":"2024","unstructured":"Buddhadev SS, C Garala KSS, Rahamathulla M, Ahmed MM, Farhana SA, Pasha I. Quality by design aided self-nano emulsifying drug delivery systems development for the oral delivery of benidipine: improvement of biopharmaceutical performance. Drug Deliv. 2024, 31:2288801. 10.1080\/10717544.2023.2288801","journal-title":"Drug Deliv"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.powtec.2016.02.023","article-title":"Solid self-nanoemulsifying systems of olmesartan medoxomil: formulation development, nicromeritic characterization, in vitro and in vivo evaluation","volume":"294","author":"Beg S","year":"2016","unstructured":"Beg S, Katare OP, Saini S, Garg B, Khurana RK, Singh B.. Solid self-nanoemulsifying systems of olmesartan medoxomil: formulation development, nicromeritic characterization, in vitro and in vivo evaluation. Powder Technol. 2016, 294:93-104. 10.1016\/j.powtec.2016.02.023","journal-title":"Powder Technol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2023.123578","article-title":"Impact of carrier hydrophilicity on solid self nano-emulsifying drug delivery system and self nano-emulsifying granule system","volume":"648","author":"Kim JS","year":"2023","unstructured":"Kim JS, Din FU, Cho HJ, et al.. Impact of carrier hydrophilicity on solid self nano-emulsifying drug delivery system and self nano-emulsifying granule system. Int J Pharm. 2023, 648:123578. 10.1016\/j.ijpharm.2023.123578","journal-title":"Int J Pharm"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/ph15010068","article-title":"Development of 3D-printed, liquisolid and directly compressed glimepiride tablets, loaded with black seed oil self-nanoemulsifying drug delivery system: in vitro and in vivo characterization","volume":"15","author":"Ahmed TA","year":"2022","unstructured":"Ahmed TA, Alotaibi HA, Alharbi WS, Safo MK, El-Say KM. Development of 3D-printed, liquisolid and directly compressed glimepiride tablets, loaded with black seed oil self-nanoemulsifying drug delivery system: in vitro and in vivo characterization. Pharmaceuticals (Basel). 2022, 15:10.3390\/ph15010068","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S377686","article-title":"Development and evaluation of self-emulsifying drug-delivery system-based tablets for simvastatin, a BCS class II drug","volume":"17","author":"Bashir MA","year":"2023","unstructured":"Bashir MA, Khan A, Shah SI, et al.. Development and evaluation of self-emulsifying drug-delivery system-based tablets for simvastatin, a BCS class II drug. Drug Des Devel Ther. 2023, 17:261-72. 10.2147\/DDDT.S377686","journal-title":"Drug Des Devel Ther"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.mprp.2020.06.061","article-title":"An experimental investigation on accuracy of Hausner ratio and Carr index of powders in additive manufacturing processes","volume":"76","author":"Kaleem MA","year":"2021","unstructured":"Kaleem MA, Alam MZ, Khan M, Jaffery SH, Rashid B. An experimental investigation on accuracy of Hausner ratio and Carr index of powders in additive manufacturing processes. Metal Powder Report. 2021, 76:S50-4. 10.1016\/j.mprp.2020.06.061","journal-title":"Metal Powder Report"},{"key":"ref18","article-title":"Aulton's Pharmaceutics: The Design and Manufacture of Medicines","author":"Aulton ME","year":"2013","unstructured":"Aulton ME, Taylor KM. Aulton's Pharmaceutics: The Design and Manufacture of Medicines. Elsevier Health Sciences, Edinburgh; 2013."},{"key":"ref19","doi-asserted-by":"crossref","DOI":"10.1007\/s12247-015-9233-6","article-title":"Evaluation of surfactant effect on self micro emulsifying drug delivery system (SMEDDS) of lercanidipine hydrochloride: formulation and evaluation","volume":"10","author":"Akula S","year":"2015","unstructured":"Akula S, Gurram AK, Devireddy SR, Deshpande PB. Evaluation of surfactant effect on self micro emulsifying drug delivery system (SMEDDS) of lercanidipine hydrochloride: formulation and evaluation. J Pharm Innov. 2015, 10:374-87.","journal-title":"J Pharm Innov"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S95905","article-title":"Self-emulsifying drug delivery systems as a tool to improve solubility and bioavailability of resveratrol","volume":"10","author":"Balata GF","year":"2016","unstructured":"Balata GF, Essa EA, Shamardl HA, Zaidan SH, Abourehab MA. Self-emulsifying drug delivery systems as a tool to improve solubility and bioavailability of resveratrol. Drug Des Devel Ther. 2016, 10:117-28. 10.2147\/DDDT.S95905","journal-title":"Drug Des Devel Ther"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.31351\/vol27iss2pp93-101","article-title":"Formulation and characterization of bromocriptine mesylate as liquid self-nano emulsifying drug delivery system","volume":"3597","author":"Hussein ZA","unstructured":"Hussein ZA, Rajab NA. Formulation and characterization of bromocriptine mesylate as liquid self-nano emulsifying drug delivery system. Iraqi J Pharm Sci. 3597:93-101. 10.31351\/vol27iss2pp93-101","journal-title":"Iraqi J Pharm Sci"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.31351\/vol32issSuppl.pp271-282","article-title":"Study the effect of formulation variables on preparation of nisoldipine loaded nano bilosomes","volume":"3597","author":"Al-Edhari GH","year":"2023","unstructured":"Al-Edhari GH, Al Gawhari FJ. Study the effect of formulation variables on preparation of nisoldipine loaded nano bilosomes. Iraqi J Pharm Sci. 2023, 3597:271-82. 10.31351\/vol32issSuppl.pp271-282","journal-title":"Iraqi J Pharm Sci"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.31351\/vol29iss2pp70-79","article-title":"Formulation and evaluation of ondansetron HCl nanoparticles for transdermal delivery","volume":"29","author":"Noor AH","year":"2020","unstructured":"Noor AH, Ghareeb MM. Formulation and evaluation of ondansetron HCl nanoparticles for transdermal delivery. Iraqi J Pharm Sci. 2020, 29:70-9. 10.31351\/vol29iss2pp70-79","journal-title":"Iraqi J Pharm Sci"},{"key":"ref24","article-title":"Nanoemulsion formulation of leflunomide for transdermal delivery: preparation and characterization","volume":"13","author":"Nashat BI","year":"2023","unstructured":"Nashat BI, Al-Kinani KK. Nanoemulsion formulation of leflunomide for transdermal delivery: preparation and characterization. Int J Drug Deliv Technol. 2023, 13:57-65.","journal-title":"Int J Drug Deliv Technol"},{"key":"ref25","article-title":"Natural oil nanoemulsion-based gel vehicle for enhancing antifungal effect of topical luliconazole","volume":"65","author":"Kmkm AM","year":"2023","unstructured":"Kmkm AM, Ghareeb MM. Natural oil nanoemulsion-based gel vehicle for enhancing antifungal effect of topical luliconazole. J Fac Med Baghdad. 2023, 65:65-73.","journal-title":"J Fac Med Baghdad"},{"key":"ref26","article-title":"Design and characterization of lercanidipine hcl microcrystalline formulation for solubility and dissolution enhancement","author":"Derkar GK","year":"2016","unstructured":"Derkar GK, Bhat MR, Randive KH, Chimkode RM. Design and characterization of lercanidipine hcl microcrystalline formulation for solubility and dissolution enhancement. Int J Appl Res Eng. 2016, 223-7.","journal-title":"Int J Appl Res Eng"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13040467","article-title":"Studies on surfactants, Cosurfactants, and oils for prospective use in formulation of ketorolac tromethamine ophthalmic nanoemulsions","volume":"13","author":"Smail SS","year":"2021","unstructured":"Smail SS, Ghareeb MM, Omer HK, Al-Kinani AA, Alany RG. Studies on surfactants, Cosurfactants, and oils for prospective use in formulation of ketorolac tromethamine ophthalmic nanoemulsions. Pharmaceutics. 2021, 13:467. 10.3390\/pharmaceutics13040467","journal-title":"Pharmaceutics"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-012-9865-5","article-title":"Development, optimization, and characterization of solid self-nanoemulsifying drug delivery systems of valsartan using porous carriers","volume":"13","author":"Beg S","year":"2012","unstructured":"Beg S, Swain S, Singh HP, Patra ChN, Rao ME. Development, optimization, and characterization of solid self-nanoemulsifying drug delivery systems of valsartan using porous carriers. AAPS PharmSciTech. 2012, 13:1416-27. 10.1208\/s12249-012-9865-5","journal-title":"AAPS PharmSciTech"},{"key":"ref29","article-title":"Handbook of Pharmaceutical Excipients","author":"Rowe RC","year":"2009","unstructured":"Rowe RC, Sheskey PJ, Quinn ME. Handbook of Pharmaceutical Excipients. Libros Digitales, London; 2009."},{"key":"ref30","article-title":"Preparation and optimization of olanzapine as transdermal nanoparticles delivery system","volume":"6","author":"Al-Shaibani AJN","year":"2024","unstructured":"Al-Shaibani AJN, Ghareeb MM. Preparation and optimization of olanzapine as transdermal nanoparticles delivery system. Al-Rafidain J Med Sci. 2024, 6:76-81.","journal-title":"Al-Rafidain J Med Sci"},{"key":"ref31","article-title":"Application of hydrophilic lipophilic difference theory for fenofibrate formulation as a self-emulsifying drug delivery system","volume":"85","author":"Sadeq HJ","year":"2023","unstructured":"Sadeq HJ, Ghareeb MM, Fadhil AA. Application of hydrophilic lipophilic difference theory for fenofibrate formulation as a self-emulsifying drug delivery system. Colloid J. 2023, 85:140-50.","journal-title":"Colloid J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/266385-unveiling-the-preparation-and-characterization-of-lercanidipine-hydrochloride-in-an-oral-solid-self-nanoemulsion-for-enhancing-oral-delivery","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T15:06:09Z","timestamp":1720883169000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/266385-unveiling-the-preparation-and-characterization-of-lercanidipine-hydrochloride-in-an-oral-solid-self-nanoemulsion-for-enhancing-oral-delivery"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,13]]},"references-count":31,"URL":"https:\/\/doi.org\/10.7759\/cureus.64468","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,13]]}}}